ArticleEuropean journal of endocrinology2023

Mendelian randomisation reveals Sodium-glucose Cotransporter-1 inhibition's potential in reducing Non-Alcoholic Fatty Liver Disease risk.

Laurence J Dobbie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.